Anders Harfstrand

Biography

Dr. Anders Harfstrandis a Chief Executive Office appointed for the BBB therapeutics founded in 2003, Netherlands.As per the BBB’s commitment to providing therapeutic solutions in neuro-oncology, most importantly demonstrating clinical proof of concept for 2B3-101, the lead compound to treat metastatic brain tumors, scheduled to complete a Phase 2 trial in a few months.“Through these important management additions, BBB Therapeutics has transitioned to a development-focused, clinical stage company nearing a significant inflection point in treating severe diseases of the brain,” adds Patrick Krol, Chairman of the Supervisory Board and Managing Partner at Aescap Venture. “This advance is represented in the company’s new name and highly focused strategy.”

Research Interest

neuro-oncology, brain tumors